To access this element change to forms mode OFF
Grant Award View - GA65839
Retinal stem cell therapy in the immunoprivileged eye
GA ID:
GA65839
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$751,368.12
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Retinal stem cell therapy in the immunoprivileged eye
Purpose:
Approximately 1.3 million Australians above the age of 50 show clinical evidence of age-related macular degeneration (AMD). Treatment options are limited and only partially effective, and 17 percent of current patients will suffer loss of vision or blindness, due to the death of photoreceptor cells in the retina. We aim to generate retinal pigment epithelial cells from stem cells and safely transplant them into the eye, to halt or reverse vision loss by preventing the death of photoreceptor cells.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1186742
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Bond University
Recipient ABN:
88 010 694 121
Grant Recipient Location
Suburb:
Robina
Town/City:
Robina
Postcode:
4226
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA